Loading...
XJPX
2784
Market cap2.47bUSD
Jul 10, Last price  
2,201.50JPY
1D
-1.10%
1Q
-11.30%
Jan 2017
13.83%
IPO
69.35%
Name

Alfresa Holdings Corp

Chart & Performance

D1W1MN
XJPX:2784 chart
P/E
9.58
P/S
0.13
EPS
229.73
Div Yield, %
3.00%
Shrs. gr., 5y
-3.00%
Rev. gr., 5y
3.52%
Revenues
3.10t
+4.83%
1,589,842,000,0001,769,454,000,0001,934,868,000,0002,059,269,000,0002,183,345,000,0002,333,256,000,0002,387,511,000,0002,504,504,000,0002,421,162,000,0002,576,405,000,0002,551,919,000,0002,602,925,000,0002,640,529,000,0002,698,555,000,0002,610,521,000,0002,585,643,000,0002,696,069,000,0002,858,500,000,0002,961,051,000,0003,104,064,000,000
Net income
41.75b
+52.41%
11,941,000,00016,177,000,0005,565,000,00010,497,000,0006,587,000,0006,604,000,00020,771,000,00025,566,000,00022,922,000,00034,975,000,00030,894,000,00035,590,000,00041,725,000,00040,273,000,00024,500,000,00032,182,000,00025,787,000,00029,559,000,00027,390,000,00041,746,000,000
CFO
38.57b
+583.92%
39,993,000,000-8,246,000,00032,963,000,0006,898,000,00052,233,000,00014,620,000,00082,339,000,000-27,507,000,00035,813,000,00037,836,000,00034,342,000,00047,575,000,00046,880,000,00033,828,000,000-21,191,000,00036,546,000,00013,086,000,00086,379,000,0005,639,000,00038,566,000,000
Dividend
Sep 29, 202635 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Alfresa Holdings Corp. engages in the management of its subsidiaries that deal with wholesaling, manufacturing, import, and export of pharmaceutical products, diagnostic reagents, and medical devices. It operates through the following segments: Ethical Pharmaceuticals Wholesaling, Self-Medication Products Wholesaling, Manufacturing, and Medical-related. The Ethical Pharmaceuticals Wholesaling segment provides wholesale prescription drugs, medical diagnostic reagents, medical devices, equipment, and materials to hospitals, clinics, dispensing pharmacies, and other institutions. The Self-Medication Products Wholesaling segment sells over-the-counter drugs, health food, and supplements. The Manufacturing segment manufactures and markets pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices. The Medical-related segment offers medical services through its dispensing pharmacies. The company was founded on September 29, 2003 and is headquartered in Tokyo, Japan.
IPO date
Sep 29, 2003
Employees
11,772
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT